Effect of RA233 on Platelet Function In Vitro
- 11 April 1970
- Vol. 2 (5701) , 83-86
- https://doi.org/10.1136/bmj.2.5701.83
Abstract
RA233, a new pyrimido-pyrimidine compound, is a powerful inhibitor of platelet function tested in vitro; it inhibits calcium and adenosine diphosphate (A.D.P.)-induced platelet aggregation, inhibits the retention of platelets by glass beads, decreases the release of platelet factor 3 by kaolin, and inhibits clot retraction. In some in-vitro systems RA233 is significantly more potent that its analogue RA433 in inhibiting platelet function.Keywords
This publication has 13 references indexed in Scilit:
- Action of a Pyrimido-pyrimidine Compound on Platelet Behaviour in VitroBMJ, 1969
- The Effect on Dipyridamole on Platelet Aggregation and AdhesivenessScottish Medical Journal, 1968
- EFFECT OF A PYRIMIDO-PYRIMIDINE COMPOUND ON PLATELET BEHAVIOUR IN VITRO AND IN VIVOThe Lancet, 1968
- Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve ReplacementNew England Journal of Medicine, 1968
- THROMBO‐EMBOLISM AND INCREASED PLATELET ADHESIVENESS IN POST‐SPLENECTOMY THROMBOCYTOSISAustralasian Annals of Medicine, 1966
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965
- EFFECT OF ANTICOAGULANT DRUGS ON PLATELET AGGREGATION IN THE CHANDLER'S TUBEThe Lancet, 1965
- THROMBOSIS.1964
- Platelet Clumping in vivoNature, 1963
- Factors influencing thrombus formation in vivoThe American Journal of Medicine, 1962